- US12540131utility2026N-(heteroaryl) Quinazolin-2-amine Derivatives as LRRK2 Inhibitors, Pharmaceutical Compositions, and Uses Thereof0 cites
- US12540132utility2026Preparation of Tetrahydroindazole Derivatives as Novel Diacylglyceride O-acyltransferase 2 Inhibitors0 cites
- US12534458utility2026Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors0 cites
- US12534530utility2026Combination of a PD-1 Antagonist and a VEGFR Inhibitor for Treating Cancer0 cites
- US12529702utility2026Scoring Methods for Anti-pd Therapy Eligibility and Compositions for Performing Same0 cites
- US12528786utility2026Plasma Kallikrein Inhibitors0 cites
- US12509509utility2025Solution Formulations of Engineered Anti-il-23p19 Antibodies0 cites
- US12497362utility2025Cyclopentapyrrole Orexin Receptor Agonists0 cites
- US12497403utility2025Factor Xia Inhibitors0 cites
- US12497405utility2025Bicyclic Heterocycle Compounds Methods of Use Thereof for the Treatment of Herpes Viruses0 cites
- US12492183utility2025Tetrahydroquinazoline Derivatives as Selective Cytotoxic Agents0 cites
- US12492187utility2025Factor XI Activation Inhibitors0 cites
- US12466840utility2025Small Molecule Inhibitors of KRAS Proteins0 cites
- US12459927utility2025Plasma Kallikrein Inhibitors0 cites
- US12459933utility2025Compounds and Methods of Use Thereof as Antibacterial Agents0 cites
- US12458632utility2025Treatment of Migraine0 cites
- US12458633utility2025Treatment of Migraine0 cites
- US12454525utility2025IL4I1 Inhibitors and Methods of Use0 cites